Stay updated on Obinutuzumab in SLE: Clinical Trial
Sign up to get notified when there's something new on the Obinutuzumab in SLE: Clinical Trial page.

Latest updates to the Obinutuzumab in SLE: Clinical Trial page
- ChecktodayChange DetectedA site-wide NIH notice appears above the study record, announcing a website transition and explaining that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.4%

- Check7 days agoChange DetectedThe site footer’s revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check28 days agoChange DetectedLatest update dated 2026-09-23 (version 57, with prior entry 2026-08-28) adds core study record sections—Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Documents, and Contacts/Locations. It also includes a Quality Control Review Has Not Concluded notice.SummaryDifference0.7%

- Check35 days agoChange DetectedA new revision entry, v3.7.0, was added to the study history and the older v3.6.6 entry was removed. This update changes the page's version log without modifying the underlying study data.SummaryDifference0.1%

- Check50 days agoChange DetectedResults Submitted was added to the study record history and No Results Posted was removed, indicating that the study's results have been submitted for posting.SummaryDifference0.1%

Stay in the know with updates to Obinutuzumab in SLE: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in SLE: Clinical Trial page.